B0F.F PAXMAN AB

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
5.51 EUR
Close of Nov 11, 2026
3.78 6.02
Market cap
EUR 128M
P/E
-
P/B
3.44x
ROE
1.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is B0F.F undervalued?

Graham number

The Graham number of PAXMAN AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PAXMAN AB fundamental analysis

No fundamental analysis for PAXMAN AB yet.

PAXMAN AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PAXMAN AB

Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized form of scalp cooling for the prevention of chemotherapy-induced alopecia. It also engages in the development of a medical cryocompression device for the prevention of chemotherapy-induced peripheral neuropathy. The company was founded in 1996 and is based in Ka…

Full company profile